Clinical Trial Update: Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of DVS SR in healthy Japanese women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasomotor Symptoms

Drugs mentioned

• DVS SR

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Vasomotor Symptoms | Phase 1 | Status: COMPLETED